|
|
|
|
|
|
|
|
Complete list of visuals in the Virology PowerPoint Learning Series 2000 |
|
|
|
|
|
|
|
|
Visual in bold displayed as a thumbnail |
|
|
|
|
|
1. |
|
Introduction and Methods of Study |
1 |
|
Human Virology title slide |
2 |
|
VIRUS structure color scheme |
3 |
|
One step growth cycle graph of events |
4 |
|
Graph of component formation |
5 |
|
Hemagglutination Assay |
6 |
|
Rate Zonal Centrifugation |
7 |
|
Restriction Endonuclease Cleavage Map |
8 |
|
Time Line: Jenner |
9 |
|
Time Line: Iwansowski |
10 |
|
Time Line: Virus - Poison |
11 |
|
Time Line: Rous |
12 |
|
Time Line: Shope |
13 |
|
Time Line: Stanley |
14 |
|
Time Line: Hershey |
15 |
|
Time Line: Fiers |
16 |
|
Time Line: Temin |
17 |
|
Time Line: Gallo, Montagnier |
|
|
|
|
|
|
2. |
|
Structure and Components |
18 |
|
STRUCTURE & COMPONENTS title |
19 |
|
DNA properties |
20 |
|
RNA properties |
21 |
|
VIRUS GENOMES comparing DNA & RNA forms |
22 |
|
Cap STRUCTURE chemical structure |
23 |
|
mRNA STRUCTURE showing Cap & Poly A |
24 |
|
Capsid Functions |
25 |
|
Helical & Icosahedral Viral Symmetry |
26 |
|
CAPSOMER ARRANGEMENT |
27 |
|
ENVELOPED HELICAL NUCLEOCAPSID |
28 |
|
HOST CELL MEMBRANE |
29 |
|
General Enveloped Structure, Interior |
30 |
|
General Enveloped Structure, Exterior |
31 |
|
Structure of PEPLOMER |
|
|
|
|
|
|
3. |
|
Classification |
32 |
|
CLASSIFICATION SYSTEMS title |
33 |
|
Diagram of 6 DNA VIRUS FAMILIES |
34 |
|
Diagram of 11 RNA VIRUS FAMILIES |
35 |
|
DNA Classification Chart |
36 |
|
RNA ClassiDcation Chart |
37 |
|
Transcription Classification Chart by Class |
38 |
|
Transcription Classification w/ Family Names |
39 |
|
DNA Genome forms |
|
|
|
|
|
|
4. |
|
Multiplication |
40 |
|
MULTIPLICATION title |
41 |
|
SPECIFICITY OF ATTACHMENT of peplomer |
42 |
|
PROTEOLYSIS PREVENTS ATTACHMENT |
43 |
|
Electrostatic Peplomer attachment |
44 |
|
Non-enveloped viral penetration |
45 |
|
Enveloped viral penetration |
46 |
|
Injection of Nucleic Acid into nucleus |
47 |
|
VIRUS MULTIPLICATION LOCATIONS table |
48 |
|
COMPONENTS FOR DNA REPLICATION text |
49 |
|
COMPONENTS FOR DNA REPLICATION cont. |
50 |
|
Replication of Genome of + STRAND RNA VIRUS |
51 |
|
Replication of Genome of - STRAND RNA VIRUS |
52 |
|
TRANSCRIPTION OF DNA TO mRNA |
53 |
|
"TRANSCRIPTION" of segmented genome viruses |
54 |
|
Protein sythesis "Macrocycle" |
55 |
|
Ribosome Minicycle /tRNAfmet, tRNAarg |
56 |
|
Ribosome Minicycle /Binding of Aminoacyl - tRNA |
57 |
|
Ribosome Minicycle /Peptide Bond Formation |
58 |
|
Ribosome Minicycle/Translocation |
59 |
|
Protein Interactions |
60 |
|
Maturation and Budding of Enveloped Virion |
61 |
|
Membrane Layer |
62 |
|
Viral Glycoproteins |
63 |
|
Bud |
64 |
|
Budding Virion |
65 |
|
Free Infectious Virion |
66 |
|
Viral Life Cycle |
|
|
|
|
|
|
5. |
|
Host Defense Mechanisms |
67 |
|
HOST DEFENSE MECHANISMS title |
68 |
|
INTERFERON TYPE / PRODUCED BY text |
69 |
|
Partial Amino Acid Sequences of Human Interferons |
70 |
|
Recombinant DNA formation of Interferon |
71 |
|
SYNTHESIS OF INTERFERON |
72 |
|
INDUCTION CF NEW PROTEINS |
73 |
|
PROTECTION BY INTERFERON |
74 |
|
Ig Class Structure |
75 |
|
Anamnestic response graph of Ag Injection |
76 |
|
Graph comparing IB responses |
77 |
|
T-Killer Cell activity |
78 |
|
Acycloguanosine inhibition |
79 |
|
Process of antiviral drug licensing |
80 |
|
Nucleoside Analogs |
81 |
|
Cytosine Arabinoside |
82 |
|
Adenine Arabinoside |
83 |
|
5 - Bromodeoxyuridine |
84 |
|
5 - lododeoxyruidine |
85 |
|
Triflourothymidine |
86 |
|
Thymidine |
87 |
|
Azidothymidine |
88 |
|
Acycloguanosine |
89 |
|
Amantidine |
|
|
|
|
|
|
6. |
|
Parvoviridae |
90 |
|
IMPORTANT ASPECTS text |
91 |
|
Structure Data |
92 |
|
Proteins MW FUNCTION text |
93 |
|
DISTINCTIVE CHARACTERISTICS text |
94 |
|
GENERA HOST text |
95 |
|
Structure of DNA (3' end) |
96 |
|
Autonomous & Adeno-associated viruses |
97 |
|
DNA replication / beginning strand |
98 |
|
DNA replication / Template ~ Primer End |
99 |
|
DNA replication / New DNA strand formed |
100 |
|
DNA replication / specific NICK formed |
101 |
|
DNA replication / unfolding |
102 |
|
DNA replication / completion of cycle |
|
|
|
|
|
|
7. |
|
Papovaviridae |
103 |
|
IMPORTANT ASPECTS text |
104 |
|
Structure & Data |
105 |
|
PROTEINS MW FUNCTION text |
106 |
|
GENERA HOST text |
107 |
|
Circular Bidirectional Model |
108 |
|
Early & Late Transcription Series /Precursor mRNA |
109 |
|
Early & Late Transcription Series /SMALL T ANTIGEN |
110 |
|
Early & Late Transcription Series /SMALL T ANTIGEN |
111 |
|
Early & Late Transcription Series /LARGE T ANTIGEN |
112 |
|
Early & Late Transcription Series /LARGE T ANTIGEN |
113 |
|
Early & Late Transcription Series /Precursor mRNA |
114 |
|
Early & Late Transcription Series /VPI |
115 |
|
Early & Late Transcription Series /VPI |
116 |
|
Early & Late Transcription Series /VP2 |
117 |
|
Early & Late Transcription Series /VP2 |
118 |
|
Early & Late Transcription Series /VP3 |
119 |
|
Early & Late Transcription Series /VP3 |
120 |
|
COMMCN WART data text |
121 |
|
FLAT WART data text |
122 |
|
PLANTAR WART data text |
123 |
|
GENITAL WART data text |
124 |
|
LARYNGEAL WART data text |
125 |
|
EPIDERMODISPLASiA VERUCIFORMIS data |
126 |
|
Cell transformation by polyomaviruses |
127 |
|
FIRST GREAT BIOLOGICAL DISASTER |
|
|
|
|
|
|
8. |
|
Adenoviridae |
128 |
|
IMPORTANT ASPECTS text |
129 |
|
Structure & Data |
130 |
|
Structure & proteins / cross section |
131 |
|
DISEASE - ASSOCIATED VIRUSES |
132 |
|
Subgroups of Human Adenoviruses |
133 |
|
Multiplication Sequence |
134 |
|
Multiplication Sequence /Structure |
135 |
|
Multiplication Sequence /Initiation |
136 |
|
Multiplication Sequence /Elongation |
137 |
|
Multiplication Sequence /Completion |
138 |
|
TRANSCRlPTION /Early Proteins |
139 |
|
TRANSCRlPTION /Late Virion Proteins |
140 |
|
TRANSCRlPTION /Late Virion Proteins |
141 |
|
TRANSCRlPTION /Cutting & Poly A Addition |
142 |
|
TRANSCRlPTION /Splicing & Capping |
143 |
|
Maturation of late mRNA |
144 |
|
ACUTE RESPIRATORY DISEASE (ARD) |
145 |
|
INFANT RESPIRATORY DISEASE |
146 |
|
CONJUCTIVITIS (SWIMMING POOL) |
147 |
|
KERATO CONJUNCTIVITIS |
|
|
|
|
|
|
9. |
|
Herpesviridae |
148 |
|
IMPORTANT ASPECTS text |
149 |
|
Structure & Data |
150 |
|
Herpes cross section |
151 |
|
HEPADNAVIRIDAE Stucture & Data |
152 |
|
DNA FORMS ORIENTATION OF L & S DOMAINS |
153 |
|
ALPHA HERPESVIRUS text |
154 |
|
BETA HERPESVIRUS text |
155 |
|
GAMMA HERPESVIRUS text |
156 |
|
SEQUENCE OF TRANSCRIPTION EVENTS graph |
157 |
|
"ROLLING CIRCLE" Replication Model |
158 |
|
"ROLLING CIRCLE" Replication Model /Circulization |
159 |
|
"ROLLING CIRCLE" Replication Model /Replication |
160 |
|
"ROLLING CIRCLE" Replication Model /Replication |
161 |
|
"ROLLING CIRCLE" Replication Model /Replication |
162 |
|
"ROLLING CIRCLE" Replication Model /Cutting & Repair |
163 |
|
HERPES SIMPLEX TYPE I PRIMARY INFECTION |
164 |
|
HERPES SIMPLEX TYPE I LATENT INFECTION |
165 |
|
HERPES SIMPLEX TYPE I RECURRENT INFECTION |
166 |
|
HERPES SIMPLEX TYPE 2 PRIMARY INFECTION |
167 |
|
HERPES SIMPLEX TYPE 2 LATENT INFECTION |
168 |
|
HERPES SIMPLEX TYPE 2 RECURRENT INFECTION |
169 |
|
VARICELLA ZOSTER PRIMARY INFECTION |
170 |
|
VARICELLA ZOSTER LATENT INFECTION |
171 |
|
VARICELLA ZOSTER RECURRENT INFECTION |
172 |
|
VARICELLA ZOSTER SHINGLES |
173 |
|
EPSTEIN-BARR VIRUS |
|
|
|
|
|
|
10. |
|
Poxviridae |
174 |
|
IMPORTANT ASPECTS text |
175 |
|
Structure Data |
176 |
|
GENERA CHARACTERISTIC MEMBERS text |
177 |
|
Multiplication cycle sequence of events |
178 |
|
VIRUS IMMUNIZATION SCHEDULE text |
179 |
|
VIRAL VACCINES NOW AVAILABLE text |
180 |
|
VIRAL VACCINES Under Development text |
181 |
|
VACCINATION RESULTS text |
182 |
|
World Health Organization |
183 |
|
World Map Smallpox 1967 |
184 |
|
World Map Smallpox 1972 |
185 |
|
World Map Smallpox 1975 |
186 |
|
World Map Smallpox 1978 |
|
|
|
|
|
|
11. |
|
Picornaviridae |
187 |
|
IMPORTANT ASPECTS text |
188 |
|
Structure & Data |
189 |
|
GENERA CHARACTERISTIC MEMBERS text |
190 |
|
CORONAVIRIDAE Structure and Data |
191 |
|
PRODUCTION & MATURATION OF POLYPROTEIN |
192 |
|
PROTEIN CLEAVAGE |
193 |
|
PENTON AGGREGATE |
194 |
|
PROCAPSID AGGREGATION |
195 |
|
INSERTION OF VIRAL RNA |
196 |
|
Provirion - Virion |
197 |
|
RHINOVIRUSES - Common cold disease |
198 |
|
ENTEROVIRUSES / DISEASES text |
199 |
|
HUMAN POLIOMYELITIS course of infection |
200 |
|
SALK and SABIN Polio vaccine text |
|
|
|
|
|
|
12. |
|
Arboviruses |
201 |
|
Arthropod borne and related viruses |
202 |
|
FAMILIES INCLUDE: text |
203 |
|
TOGAVIRIDAE Structure & Data |
204 |
|
FLAVIVIRIDAE Structure & Data |
205 |
|
BUNYAVIRIDAE Structure & Data |
206 |
|
REOVIRIDAE Structure & Data |
207 |
|
ARENAVIRIDAE Structure & Data |
208 |
|
RHABDOVIRIDAE Structure & Data |
209 |
|
GENERA/ MEMBERS TOGAVIRIDAE text |
210 |
|
GENERA/ MEMBERS FLAVIVIRIDAE text |
211 |
|
GENERA/ MEMBERS BUNYAVIRIDAE text |
212 |
|
GENERA/ MEMBERS REOVIRIDAE text |
213 |
|
GENERA/ MEMBERS ARENAVIRIDAE text |
214 |
|
GENERA/ MEMBERS RHABDOVIRIDAE text |
215 |
|
EARLY & LATE Protein Synthesis |
216 |
|
Formation of Glycoprotein Progression |
217 |
|
Formation of Glycoprotein Progression /formation of E3 |
218 |
|
Formation of Glycoprotein Progression /formation of E2 |
219 |
|
Formation of Glycoprotein Progression /formation of E1 |
220 |
|
Formation of Glycoprotein Progression /Completion |
221 |
|
MINUS STRAND RNA VIRUSES mulitipication |
222 |
|
ARBOVIRUS INFECTIONS - EARLY SYMPTOMS |
223 |
|
ENCEPHALITIS |
224 |
|
RASH FEVERS |
225 |
|
HEMORRHAGIC FEVERS |
226 |
|
RUBELLA |
227 |
|
CONGENITAL RUBELLA SYNDROME text |
228 |
|
ARENAVIRUSES - Lassa Fever |
229 |
|
REOVIRUS - Colorado Tick Fever |
230 |
|
ROTAVIRUS - Epidemic Diarrhea |
231 |
|
RHABODOVIRUS - Rabies |
232 |
|
ARENAVIRUS - LCM |
|
|
|
|
|
|
13. |
|
Paramyxoviridae |
233 |
|
IMPORTANT ASPECTS text |
234 |
|
Structure & Data |
235 |
|
PROTEINS MW FUNCTION text |
236 |
|
PARAMYXOVIRIDAE Cross Section |
237 |
|
GENERA - RELATED DISEASES text |
238 |
|
Protein Synthesis sequence of events |
239 |
|
MEASLES INFECTION events graph |
240 |
|
MUMPS INFECTION events graph |
241 |
|
PNEUMOVIRUS |
242 |
|
MORBILLAVIRUS |
243 |
|
PARAMYXOVIRUS |
|
|
|
|
|
|
14. |
|
Orthomyxoviridae |
244 |
|
IMPORTANT ASPECTS text |
245 |
|
Structure & Data |
246 |
|
Influenza Cross Section of Structure |
247 |
|
PROTEINS MW FUNCTION text |
248 |
|
PAGE OF INFLUENZA VIRUS PROTEINS graph |
249 |
|
Viral Multiplication Sequence |
250 |
|
Production of mRNA |
251 |
|
INFLUENZA disease |
252 |
|
ANTIGENIC DRIFT sequence of events |
253 |
|
ANTIGENIC SHIFT sequence of events |
254 |
|
Time line showing Type A prevalence |
|
|
|
|
|
|
15. |
|
Retroviridae |
255 |
|
IMPORTANT ASPECTS text |
256 |
|
Structure & Data |
257 |
|
Cross Section of Structure |
258 |
|
PROTEINS MW FUNCTION text |
259 |
|
GENERA - MEMBERS |
260 |
|
Oncogene table |
261 |
|
Oncogene table |
262 |
|
Assay for Human Oncogene |
263 |
|
Multiplication Early sequence of events |
264 |
|
Simplified sequence showing mRNA |
265 |
|
Multiplication sequence of events /Transcription |
266 |
|
Multiplication sequence of events /Assembly |
267 |
|
Retrovirus Life Cycle |
268 |
|
ACTIVATION OF ONCOGENE by Lukemia Virus |
269 |
|
Oncogenic theory |
|
|
|
|
|
|
16. |
|
Viral Pathogenesis |
270 |
|
VIRAL PATHOGENESIS title |
271 |
|
CLASSIFICATION BY INFECTION |
272 |
|
RESPIRATORY |
273 |
|
ENTERIC |
274 |
|
SKIN |
275 |
|
INJECTION |
276 |
|
CONJUNCTIVA VIRUSES |
277 |
|
SPECIFIC ORGAN VIRUSES |
278 |
|
RESPIRATORY Localized Infections |
279 |
|
RESPIRATORY TRACT VIRUSES (URTI) |
280 |
|
ENTERIC VIRUSES text |
281 |
|
SKIN RASH VIRUSES text |
282 |
|
SEXUALLY TRANSMITTED VIRUSES text |
283 |
|
GENITOURINARY VIRUSES text |
284 |
|
PRENATAL & NEONATAL VIRUSES text |
285 |
|
Time Line for Incubation |
286 |
|
VIRAL HEPATITIS |
287 |
|
HEPATITIS VIRUSES |
288 |
|
CNS VIRUSES |
289 |
|
CNS VIRUSES |
290 |
|
PERSISTENT VIRAL INFECTIONS - LATENT |
291 |
|
PERSISTENT VIRAL INFECTIONS - CHRONIC |
292 |
|
PERSISTENT VIRAL INFECTIONS - SLOW |
293 |
|
HIV-1 |
294 |
|
HIV-1 Proteins |
295 |
|
HIV-1 Viral Life Cycle |
296 |
|
HIV-1 Replication |
297 |
|
Aids Transmission |
298 |
|
Aids Progression |
299 |
|
Aids Time Line |
300 |
|
Group 1-4 Progression |
|
|
|